Carl-Gustave Pierre Saluste

Title: The Innovations of Carl-Gustave Pierre Saluste

Introduction

Carl-Gustave Pierre Saluste is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific kinases involved in cancer treatment. His work has the potential to impact the treatment of various proliferative diseases.

Latest Patents

Saluste holds a patent for "Tricyclic compounds for use as kinase inhibitors." This patent includes compounds of formula (I), which are designed to inhibit protein or lipid kinases, such as PIM family kinases (PIM-1, PIM-2, and PIM-3). These compounds are particularly useful in treating cancer and other proliferative diseases. The patent also covers pharmaceutically acceptable esters, amides, solvates, or salts of these compounds, as well as combinations comprising them.

Career Highlights

Throughout his career, Saluste has worked with prominent research institutions, including the Fundación Centro Nacional de Investigaciones Oncológicas Carlos III and the Centro Nacional de Investigaciones Oncológicas (CNIO). His research has focused on developing innovative therapeutic strategies to combat cancer.

Collaborations

Saluste has collaborated with esteemed colleagues such as Joaquín Pastor Fernández and Francisco Javier Ramos Lima. These partnerships have contributed to advancing research in the field of oncology and the development of new therapeutic agents.

Conclusion

Carl-Gustave Pierre Saluste's work in developing kinase inhibitors represents a significant advancement in cancer treatment. His innovative approach and collaborations with leading researchers highlight his commitment to improving therapeutic options for patients.